Background. In our 180 bed free-standing children's hospital, all patients admitted to intensive care units or from a nursing facility have a GenXpert MRSA nasal screen. This information is routinely used for isolation purposes, but it has increasingly been used to guide antibiotic usage when patients have a suspected infection. Previous studies have demonstrated that patients with positive MRSA screens are at higher risk for MRSA infection. The objective of this study was to evaluate the predictive value of the MRSA screen result for MRSA infection in patients with suspected respiratory infection as tested by broncheoalveolar lavage (BAL) or tracheal aspirate.
Methods. All patients admitted from January 27, 2009-September 17, 2013 who had both MRSA screening and BAL or tracheal aspirate performed were retrospectively studied. 1336 pairs of screens and cultures were analyzed for correlation of results using descriptive statistics.
Results. There were 196 positive MRSA screens (14.7%). 45 respiratory cultures were positive for MRSA. Of these 45 positive cultures, 13 had negative MRSA screens, while 32 had positive screens. Statistical analyses demonstrated a positive predictive value for the screen of 16.3% and a negative predictive value of 98.9%. Sensitivity of the screen for a positive respiratory culture was 71% and specificity was 87.3%. Relative risk of culture-positive MRSA respiratory infection with respect to positive screen result was 14.8.
Conclusion. Our study demonstrates that the MRSA nasal screen has a high negative predictive value for MRSA infection in pediatric patients with artificial airways. While patients with a positive screen are at significantly higher risk for culture positive infection, the sensitivity and positive predictive value of a positive screen are relatively low. Since patients with a negative MRSA screen have a lower risk of MRSA respiratory infection, this data could help guide clinicians toward earlier narrowing of empiric antibiotic choices in patients with MRSA screen results and pending respiratory cultures. However, clinical judgment should be used, as 29% of patients in our cohort with a culture positive MRSA respiratory infection had a negative screen. Further study is warranted to clarify the implications of these results.
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